Foley & Lardner LLP
Aryl or heteroaryl triazolone derivatives or salts thereof, or pharmaceutical compositions comprising the same
The present technology provides aryl or heteroaryl triazolone derivatives or pharmaceutically acceptable salts thereof, preparation processes thereof, pharmaceutical compositions comprising the same, and the use thereof. The aryl or heteroaryl triazolone derivatives or their pharmaceutically acceptable salts exhibit selective inhibitory activity on VAP-1 and therefore can be usefully applied, e.g., for the treatment and prophylaxis of nonalcoholic hepatosteatosis (NASH).
YUHAN CORPORATION
C C C C C C C C C C C C C C C C C
C07D C07D C07D C07D C07D C07D C07D C07D C07D C07D C07D C07D C07D C07D C07D C07D C07D
inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional
Eun Kyung Hyun Ho Sol Tae Dong Na Ry Mi Kyeong Hee Jae Tae Wang Dong Hoon Su Bin Eun Hye
Kim Choi Park Han Ha Ju Tak Kim Kim Choi Jung